Prelude Therapeutics, Inc. (PRLD)
2.09
-0.01
(-0.48%)
USD |
NASDAQ |
Feb 11, 16:00
2.085
0.00 (0.00%)
After-Hours: 20:00
Prelude Therapeutics Market Cap : 131.39M for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLife Solutions, Inc. | 1.071B |
| Immunome, Inc. | 2.147B |
| Incyte Corp. | 19.67B |
| Aclaris Therapeutics, Inc. | 367.29M |
| Relay Therapeutics, Inc. | 1.586B |
Market Cap Related Metrics
| PS Ratio | 14.10 |
| Price to Book Value | 2.245 |
| Price | 2.09 |
| Earnings Yield | -77.19% |